MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-UP-19-0006291
Dwarika Leela & Sons Private Limited
Dwarika Leela & Sons Private Limited - pharma in Chandauli, Uttar Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹7.69 Cr
▲ 4% YoY
Net profit · FY 2025
₹6.1 Lakh
Net margin 0.8%
EBITDA · FY 2025
₹12.74 Lakh
EBITDA margin 1.7%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹36.21 Lakh
Secured borrowings
Company age
10 yrs
Est. 2016
Directors on board
2
As per MCA filings
About Dwarika Leela & Sons Private Limited
Data last updated:
Dwarika Leela & Sons Private Limited is a private limited company based in Chandauli, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 13 July 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U74999UP2016PTC084853. Its GSTIN is 09AAFCD8051J1ZE (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ravi Prakash Varshney and Shashi Prakash Varshney.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.No. 564 Kailashpuri Mughalsarai, Chandauli, Uttar Pradesh, India – 232101.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.69 Cr, a growth of 4% compared to the previous year. For the same year it recorded a net profit of ₹6.1 Lakh (net margin 0.8%) and EBITDA of ₹12.74 Lakh (EBITDA margin 1.7%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years and 2% over five years.
As per MCA filings, the company has open charges of ₹36.21 Lakh on record.
Dwarika Leela & Sons Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-19-0006291). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U74999UP2016PTC084853
Registration Number 084853
Incorporation Date 13 July 2016
ROC Uttar Pradesh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-UP-19-0006291
Recognitions & Rankings of Dwarika Leela & Sons
Contact details
Dwarika Leela & Sons Private Limited's registered office is in Chandauli, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressH.No. 564 Kailashpuri Mughalsarai, Chandauli, Uttar Pradesh, India – 232101
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Dwarika Leela & Sons Private Limited, buy the company report.
Comprehensive company report
Dwarika Leela & Sons Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Dwarika Leela & Sons is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Dwarika Leela & Sons Private Limited, buy the company report.
Financials of Dwarika Leela & Sons Private Limited
FY 2025 filings availableDwarika Leela & Sons Private Limited reported revenue of ₹7.69 Cr (up 4% YoY) for FY 2025.
Revenue · FY 2025
₹7.69 Cr ▲ 4%
Net profit · FY 2025
₹6.1 Lakh margin 0.8%
EBITDA · FY 2025
₹12.74 Lakh margin 1.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 4%
3 years · compounded
▼ 4%
5 years · compounded
▲ 2%
EBITDA CAGR growth
1 year
▲ 14%
3 years · compounded
▲ 4%
5 years · compounded
▲ 8%
Revenue has grown at a compounded annual rate (CAGR) of 2% over five years, including 4% growth in the latest year. EBITDA rose 14% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹12.74 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹6.1 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.7% | ||||
| Net Profit Margin | 0.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Dwarika Leela & Sons Private Limited, buy the company report.
Board of directors of Dwarika Leela & Sons Private Limited
Dwarika Leela & Sons has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ravi Prakash Varshney | Director | 13 Jul 2016 | 10 Years 3 Months | Current |
| Shashi Prakash Varshney | Director | 13 Jul 2016 | 10 Years 3 Months | Current |
Peer comparison
Dwarika Leela & Sons Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Rebrace Pharmaceuticals Private Limited | ₹7.71 Cr (FY 2024) | 55.0% | Bishnupur, West Bengal, India | |||
| Ridhi Sidhi Medicos Private Limited | ₹7.69 Cr (FY 2025) | 5.0% | Lucknow, Uttar Pradesh, India | |||
| Dwarika Leela & Sons Private Limitedthis company | ₹7.69 Cr (FY 2025) | ₹6.1 Lakh | 0.8% | 4.0% | Chandauli, Uttar Pradesh, India | |
| Matrix Pharma-Chem (India) Private Limited | ₹7.67 Cr (FY 2025) | 6.0% | Secunderabad, Telangana, India | |||
| Space Health Care Private Limited | ₹7.62 Cr (FY 2025) | 54.0% | Indore, Madhya Pradesh, India |
To see the full peer comparison of Dwarika Leela & Sons Private Limited, buy the company report.
Auditor
Dwarika Leela & Sons Private Limited is audited by DHIRENDRA MISHRA & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DHIRENDRA MISHRA & CO | FY 2023 | 015963C |
Shareholding
The shareholding of Dwarika Leela & Sons Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Dwarika Leela & Sons Private Limited, buy the company report.
Charges & borrowings
Open charges
₹36.21 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 17 Oct 2023 | 100846427 | Others | ₹30 Lakh | Open | |
| 20 Oct 2022 | 100653306 | Others | ₹6.21 Lakh | Open |
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Dwarika Leela & Sons Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Dwarika Leela & Sons Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Dwarika Leela & Sons has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAFCD8051J1ZE | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Dwarika Leela & Sons Private Limited, buy the company report.
Recent activity
Dwarika Leela & Sons Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Ravi Prakash Varshney was appointed as Director on 13 Jul 2016.
AGM
Dwarika Leela & Sons Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Dwarika Leela & Sons Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttar Pradesh I.
Charges
A charge with Others amounted to Rs. 30.00 Lakh with Charge ID 100846427 was registered on 17 Oct 2023.
Charges
A charge with Others amounted to Rs. 6.21 Lakh with Charge ID 100653306 was registered on 20 Oct 2022.
Appointed
Ravi Prakash Varshney was appointed as Director.
Appointed
Shashi Prakash Varshney was appointed as Director.
Incorporation
13 Jul 2016
Dwarika Leela & Sons Private Limited was registered on 13 Jul 2016 with Roc Uttar Pradesh I & aged 10 years 4 months as per MCA records.
Frequently asked questions
Dwarika Leela & Sons is an active private limited company based in Chandauli, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 13 July 2016 (10+ years old) and is registered under CIN U74999UP2016PTC084853.
Dwarika Leela & Sons has 2 current directors:
- Ravi Prakash Varshney - Director
- Shashi Prakash Varshney - Director
The latest financial statements of Dwarika Leela & Sons on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Dwarika Leela & Sons is 09AAFCD8051J1ZE, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Dwarika Leela & Sons is U74999UP2016PTC084853. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dwarika Leela & Sons was incorporated on 13 July 2016, making it 10+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Dwarika Leela & Sons by revenue are Rebrace Pharmaceuticals Private Limited, Ridhi Sidhi Medicos Private Limited, Matrix Pharma-Chem (India) Private Limited, Space Health Care Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Ravi Prakash Varshney was appointed as Director on 13 Jul 2016. Shashi Prakash Varshney was appointed as Director on 13 Jul 2016.
Yes, Dwarika Leela & Sons is registered as a small enterprise under Udyam registration (number: UDYAM-UP-19-0006291).
The registered office of Dwarika Leela & Sons is at H.No. 564 Kailashpuri Mughalsarai, Chandauli, Uttar Pradesh, India – 232101.
Dwarika Leela & Sons operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages